in Newswire Published on March 27, 2024

Certain Differin Acne Treatments Contain Toxic Carcinogen Benzene, Class Action Alleges

Williams v. Galderma Laboratories, L.P.

Filed: March 18, 2024 § 1:24-cv-02222

A class action alleges Galderma has failed to warn consumers that some of its Differin acne cream products potentially contain a dangerous carcinogen.

Case Spotlight

Video Game Addiction Lawsuits

How Do I Join a Class Action Lawsuit?

ClassAction.org Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

Last Updated on March 27, 2024 — 9:33 AM

Kelsey McCroskey

kelsey@classaction.org

Kelsey works primarily on ClassAction.org’s newswire, reporting on cases as they happen.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.